Abbott , a leading technology company, has recently secured a significant order and reported its quarterly financial results, showcasing both growth and challenges in its operations.

New Order from Siemens Gamesa

ABB India has won a substantial order worth ₹173.55 crore from Siemens Gamesa Renewable Power. The contract involves the manufacturing and supply of 3.X wind turbine converters and electrical cabinets. This order underscores ABB India's strong position in the renewable energy sector and its capability to provide advanced solutions for wind power generation.

Key details of the order:

• Value: ₹173.55 crore
• Client: Siemens Gamesa Renewable Power
• Products: 3.X wind turbine converters and electrical cabinets
• Execution: From ABB India's Nelamangala factory
• Delivery Schedule: Monthly deliveries from January 2026 to December 2026

This long-term order, spanning a full year of deliveries, indicates a steady demand for ABB India's wind energy solutions and potentially signals positive growth in the renewable energy sector.

Mixed Q3 Financial Results

Alongside the new order announcement, ABB India has reported its recent quarterly financial results, presenting a mixed picture of the company's performance:

While the company demonstrated strong top-line growth with a 12.20% increase in revenue, profitability metrics showed a decline. Net profit decreased by 20.50%, and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) fell by 27.00%.

Sanjeev Sharma, Managing Director of ABB India, addressed the profitability challenges, attributing the impact to forex volatility and one-time factors. These explanations suggest that the company views the profit decline as potentially temporary, affected by external market conditions rather than fundamental business issues.

Market Response

The market appears to have responded positively to the recent developments. Following the announcement of the new order, ABB India's shares traded 0.76% higher at ₹5,039.00. This uptick suggests that investors are focusing on the company's ability to secure significant new business, potentially outweighing concerns about the short-term profitability challenges.

The combination of a major new order in the renewable energy sector and continued revenue growth, despite profitability headwinds, paints a picture of a company navigating both opportunities and challenges in a dynamic market environment.

Abbott India , a leading healthcare company, has announced the launch of its latest innovation in diabetes management - the FreeStyle Libre 2 Plus. This next-generation glucose monitoring device represents a significant advancement in continuous glucose monitoring technology, offering enhanced features to improve the lives of people managing diabetes.

Cutting-Edge Technology for Minute-by-Minute Monitoring

The FreeStyle Libre 2 Plus sets itself apart with its ability to provide continuous glucose readings every minute. This high-frequency monitoring allows users to track their glucose levels with unprecedented precision, enabling more informed decision-making about their diabetes management.

Advanced Alarm Features for User Safety

One of the standout features of the FreeStyle Libre 2 Plus is its optional alarm system. These alarms can be customized to alert users when their glucose levels fall outside of their target range, providing an extra layer of safety and peace of mind for individuals managing diabetes.

Empowering Diabetes Management

By combining minute-by-minute glucose readings with customizable alarms, the FreeStyle Libre 2 Plus aims to empower users with real-time information about their glucose levels. This continuous stream of data can help individuals and their healthcare providers make more informed decisions about insulin dosing, meal planning, and overall diabetes management strategies.

The launch of the FreeStyle Libre 2 Plus underscores Abbott India's commitment to innovation in the field of diabetes care. As the prevalence of diabetes continues to rise globally, technologies like this play a crucial role in improving the quality of life for millions of people living with the condition.

While the company has not disclosed pricing or availability details in the announcement, the introduction of the FreeStyle Libre 2 Plus is expected to be a welcome addition to the diabetes management toolkit in India, potentially benefiting a significant portion of the population affected by diabetes.